News
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
1d
Investor's Business Daily on MSNGlobus Medical Sees Relative Strength Rating Improve To 73Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...
StockStory.org on MSN1d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
Clearly, options traders are pricing in a big move for Globus Medical shares, but what is the fundamental picture for the company? Currently, Globus Medical is a Zacks Rank #3 (Hold) in the ...
Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results